PET-MR and SPECT-MR multimodality probes: development and challenges
Positron emission tomography (PET)-magnetic resonance (MR) or single photon emission computed tomography (SPECT)-MR hybrid imaging is being used in daily clinical practice. Due to its advantages over stand-alone PET, SPECT or MR imaging, in many areas such as oncology, the demand for hybrid imaging...
| Main Authors: | , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal Article |
| Language: | English |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/103390 http://hdl.handle.net/10220/47299 |
| _version_ | 1826126131900710912 |
|---|---|
| author | Yang, Chang-Tong Ghosh, Krishna Kanta Padmanabhan, Parasuraman Langer, Oliver Liu, Jiang Eng, David Ng Chee Halldin, Christer Gulyás, Balázs |
| author2 | Lee Kong Chian School of Medicine (LKCMedicine) |
| author_facet | Lee Kong Chian School of Medicine (LKCMedicine) Yang, Chang-Tong Ghosh, Krishna Kanta Padmanabhan, Parasuraman Langer, Oliver Liu, Jiang Eng, David Ng Chee Halldin, Christer Gulyás, Balázs |
| author_sort | Yang, Chang-Tong |
| collection | NTU |
| description | Positron emission tomography (PET)-magnetic resonance (MR) or single photon emission computed tomography (SPECT)-MR hybrid imaging is being used in daily clinical practice. Due to its advantages over stand-alone PET, SPECT or MR imaging, in many areas such as oncology, the demand for hybrid imaging techniques is increasing dramatically. The use of multimodal imaging probes or biomarkers in a single molecule or particle to characterize the imaging subjects such as disease tissues certainly provides us with more accurate diagnosis and promotes therapeutic accuracy. A limited number of multimodal imaging probes are being used in preclinical and potential clinical investigations. The further development of multimodal PET-MR and SPECT-MR imaging probes includes several key elements: novel synthetic strategies, high sensitivity for accurate quantification and high anatomic resolution, favourable pharmacokinetic profile and target-specific binding of a new probe. This review thoroughly summarizes all recently available and noteworthy PET-MR and SPECT-MR multimodal imaging probes including small molecule bimodal probes, nano-sized bimodal probes, small molecular trimodal probes and nano-sized trimodal probes. To the best of our knowledge, this is the first comprehensive overview of all PET-MR and SPECT-MR multimodal probes. Since the development of multimodal PET-MR and SPECT-MR imaging probes is an emerging research field, a selection of 139 papers were recognized following the literature review. The challenges for designing multimodal probes have also been addressed in order to offer some future research directions for this novel interdisciplinary research field. |
| first_indexed | 2024-10-01T06:47:42Z |
| format | Journal Article |
| id | ntu-10356/103390 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T06:47:42Z |
| publishDate | 2019 |
| record_format | dspace |
| spelling | ntu-10356/1033902020-11-01T05:25:35Z PET-MR and SPECT-MR multimodality probes: development and challenges Yang, Chang-Tong Ghosh, Krishna Kanta Padmanabhan, Parasuraman Langer, Oliver Liu, Jiang Eng, David Ng Chee Halldin, Christer Gulyás, Balázs Lee Kong Chian School of Medicine (LKCMedicine) Bimodality Imaging Probe PET-MR DRNTU::Science::Medicine Positron emission tomography (PET)-magnetic resonance (MR) or single photon emission computed tomography (SPECT)-MR hybrid imaging is being used in daily clinical practice. Due to its advantages over stand-alone PET, SPECT or MR imaging, in many areas such as oncology, the demand for hybrid imaging techniques is increasing dramatically. The use of multimodal imaging probes or biomarkers in a single molecule or particle to characterize the imaging subjects such as disease tissues certainly provides us with more accurate diagnosis and promotes therapeutic accuracy. A limited number of multimodal imaging probes are being used in preclinical and potential clinical investigations. The further development of multimodal PET-MR and SPECT-MR imaging probes includes several key elements: novel synthetic strategies, high sensitivity for accurate quantification and high anatomic resolution, favourable pharmacokinetic profile and target-specific binding of a new probe. This review thoroughly summarizes all recently available and noteworthy PET-MR and SPECT-MR multimodal imaging probes including small molecule bimodal probes, nano-sized bimodal probes, small molecular trimodal probes and nano-sized trimodal probes. To the best of our knowledge, this is the first comprehensive overview of all PET-MR and SPECT-MR multimodal probes. Since the development of multimodal PET-MR and SPECT-MR imaging probes is an emerging research field, a selection of 139 papers were recognized following the literature review. The challenges for designing multimodal probes have also been addressed in order to offer some future research directions for this novel interdisciplinary research field. Published version 2019-01-02T04:59:04Z 2019-12-06T21:11:35Z 2019-01-02T04:59:04Z 2019-12-06T21:11:35Z 2018 Journal Article Yang, C.-T., Ghosh, K. K., Padmanabhan, P., Langer, O., Liu, J., Eng, D. N. C., ... Gulyás, B. (2018). PET-MR and SPECT-MR multimodality probes: Development and challenges. Theranostics, 8(22), 6210-6232. doi:10.7150/thno.26610 https://hdl.handle.net/10356/103390 http://hdl.handle.net/10220/47299 10.7150/thno.26610 en Theranostics © 2018 Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. 23 p. application/pdf |
| spellingShingle | Bimodality Imaging Probe PET-MR DRNTU::Science::Medicine Yang, Chang-Tong Ghosh, Krishna Kanta Padmanabhan, Parasuraman Langer, Oliver Liu, Jiang Eng, David Ng Chee Halldin, Christer Gulyás, Balázs PET-MR and SPECT-MR multimodality probes: development and challenges |
| title | PET-MR and SPECT-MR multimodality probes: development and challenges |
| title_full | PET-MR and SPECT-MR multimodality probes: development and challenges |
| title_fullStr | PET-MR and SPECT-MR multimodality probes: development and challenges |
| title_full_unstemmed | PET-MR and SPECT-MR multimodality probes: development and challenges |
| title_short | PET-MR and SPECT-MR multimodality probes: development and challenges |
| title_sort | pet mr and spect mr multimodality probes development and challenges |
| topic | Bimodality Imaging Probe PET-MR DRNTU::Science::Medicine |
| url | https://hdl.handle.net/10356/103390 http://hdl.handle.net/10220/47299 |
| work_keys_str_mv | AT yangchangtong petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT ghoshkrishnakanta petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT padmanabhanparasuraman petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT langeroliver petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT liujiang petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT engdavidngchee petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT halldinchrister petmrandspectmrmultimodalityprobesdevelopmentandchallenges AT gulyasbalazs petmrandspectmrmultimodalityprobesdevelopmentandchallenges |